Humoral And Cellular Tolerization Approaches Against Autoimmunity

对抗自身免疫的体液和细胞耐受方法

基本信息

项目摘要

DESCRIPTION (provided by applicant): After carefully evaluating the merits, potential pitfalls, concerns and failures of the strategies so far proposed to treat autoimmune diseases, it was concluded that recombinant antibody and dendritic cell-based approaches would be clinically translatable modalities with the greatest likelihood of success during treatment, combined with the least concern of deleterious side effects. Importantly, the investigators collaborating in this proposal have themselves, or are collaborating with others at the University of Pittsburgh who have exceptional expertise in these approaches. This application will provide further insights into the basic mechanisms of action of the proposed approaches, in itself a compelling rationale for their selection and evaluation. To better organize these studies, it was also concluded that an Autoimmunity Center of Excellence may represent the most appropriate "umbrella" under which to consolidate the efforts of the interested clinicians and scientists of the University of Pittsburgh. The complexity of studying and developing new therapeutic approaches to treating autoimmune diseases requires a modern, multidisciplinary research climate. The synchronization of both the expertise and the technology available among the investigators within this university who are interested in the same scientific area, i.e., autoimmunity, is necessary in order to maximize the use of all of the resources in the most cost effective and academically efficient manner. Moreover the University of Pittsburgh will greatly benefit from a forum specifically dedicated to the study of autoimmunity, where both junior and established investigators within different departments and institutions, and with interdisciplinary expertise, can be drawn together with interested clinicians so that bench-to-bedside transfer can be fostered more efficiently. In order to encourage young researchers to devote their careers to the study of autoimmune ailments, especially those that affect children, it is here proposed to build an Autoimmune Center of Excellence with the specific belief that fostering of this type of career is easier within a scientifically challenging atmosphere of collegiality and intellectual discourse. Finally, having an Autoimmunity Center of Excellence in Pittsburgh entirely dedicated to a single philosophical and scientific goal: "understanding, preventing and eventually curing autoimmune diseases" will allow the creation of new scientific leads that will form the basis for more promising clinical trials.
描述(由申请人提供): 在仔细评估了迄今为止提出的治疗自身免疫性疾病的策略的优点、潜在陷阱、关注点和失败之后,得出的结论是,基于重组抗体和树突状细胞的方法将是临床上可转化的模式,在治疗期间具有最大的成功可能性,并且对有害副作用的关注最少。重要的是,参与这项提议的研究人员本身或正在与匹兹堡大学的其他人合作,他们在这些方法方面具有特殊的专业知识。这一应用将进一步深入了解拟议办法的基本作用机制,这本身就是选择和评价这些办法的令人信服的理由。为了更好地组织这些研究,还得出结论,自身免疫卓越中心可能是最合适的“保护伞”,可以巩固匹兹堡大学感兴趣的临床医生和科学家的努力。研究和开发新的治疗方法来治疗自身免疫性疾病的复杂性需要一个现代化的,多学科的研究环境。在这所大学内对同一科学领域感兴趣的研究人员之间的专业知识和技术的同步,即,为了以最具成本效益和学术效率的方式最大限度地利用所有资源,自身免疫是必要的。 此外,匹兹堡大学将从专门致力于自身免疫研究的论坛中受益匪浅,在该论坛中,不同部门和机构内的初级和成熟的研究人员以及跨学科的专业知识可以与感兴趣的临床医生聚集在一起,以便能够更有效地促进从工作台到床边的转移。为了鼓励年轻的研究人员致力于自身免疫性疾病的研究,特别是那些影响儿童的疾病,这里建议建立一个自身免疫卓越中心,具体的信念是培养这种类型的职业生涯更容易在科学上具有挑战性的气氛中的合议和知识话语。最后,在匹兹堡建立一个自身免疫卓越中心,完全致力于一个哲学和科学目标:“理解、预防并最终治愈自身免疫性疾病”,这将有助于创造新的科学线索,为更有前途的临床试验奠定基础。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Web-based primer design software for genome-scale genotyping by pyrosequencing.
  • DOI:
    10.1385/1-59745-377-3:25
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Ringquist;C. Pecoraro;Ying Lu;A. Styche;W. Rudert;P. Benos;M. Trucco
  • 通讯作者:
    S. Ringquist;C. Pecoraro;Ying Lu;A. Styche;W. Rudert;P. Benos;M. Trucco
Use of nonobese diabetic mice to understand human type 1 diabetes.
SOP3v2: web-based selection of oligonucleotide primer trios for genotyping of human and mouse polymorphisms.
SOP3v2:基于网络的寡核苷酸引物三组选择,用于人类和小鼠多态性的基因分型。
  • DOI:
    10.1093/nar/gki483
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ringquist,Steven;Pecoraro,Christopher;Gilchrist,CrystalMS;Styche,Alexis;Rudert,WilliamA;Benos,PanagiotisV;Trucco,Massimo
  • 通讯作者:
    Trucco,Massimo
Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
抗糖尿病磺酰脲类药物可独立于质膜 KATP 通道刺激胰岛素分泌。
Pyrosequencing-based strategies for improved allele typing of human leukocyte antigen loci.
基于焦磷酸测序的策略,用于改进人类白细胞抗原位点的等位基因分型。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MASSIMO M. TRUCCO其他文献

MASSIMO M. TRUCCO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MASSIMO M. TRUCCO', 18)}}的其他基金

Humoral And Cellular Tolerization Approaches Against Au*
针对 Au* 的体液和细胞耐受方法
  • 批准号:
    6872007
  • 财政年份:
    2003
  • 资助金额:
    $ 72.57万
  • 项目类别:
Humoral And Cellular Tolerization Approaches Against Au*
针对 Au* 的体液和细胞耐受方法
  • 批准号:
    6803537
  • 财政年份:
    2003
  • 资助金额:
    $ 72.57万
  • 项目类别:
Humoral And Cellular Tolerization Approaches Against Au*
针对 Au* 的体液和细胞耐受方法
  • 批准号:
    6684628
  • 财政年份:
    2003
  • 资助金额:
    $ 72.57万
  • 项目类别:
Humoral And Cellular Tolerization Approaches Against Au*
针对 Au* 的体液和细胞耐受方法
  • 批准号:
    7038210
  • 财政年份:
    2003
  • 资助金额:
    $ 72.57万
  • 项目类别:
Optical Imaging of Beta-Cell Function and Engraftment
β 细胞功能和植入的光学成像
  • 批准号:
    6666714
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:
Gene-engineered dendritic cell therapy for diabetics
针对糖尿病患者的基因工程树突状细胞疗法
  • 批准号:
    6666777
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:
Gene-engineered dendritic cell therapy for diabetics
针对糖尿病患者的基因工程树突状细胞疗法
  • 批准号:
    7119507
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:
Optical Imaging of Beta-Cell Function and Engraftment
β 细胞功能和植入的光学成像
  • 批准号:
    6574526
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:
Gene-engineered dendritic cell therapy for diabetics
针对糖尿病患者的基因工程树突状细胞疗法
  • 批准号:
    7085769
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:
Gene-engineered dendritic cell therapy for diabetics
针对糖尿病患者的基因工程树突状细胞疗法
  • 批准号:
    6575957
  • 财政年份:
    2002
  • 资助金额:
    $ 72.57万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 72.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了